Microcirculation as a novel marker of membrane biocompatibility

U Teatini1, L Ballerini, G Romei Longhena

  • 1Renal Unit, Bollate Hospital, Bollate, Milan, Italy. nefrologiab@aogarbagnate.lombardia.it

Summary

Microcirculation monitoring using transcutaneous oxygen pressure (TcPO2) reveals differences in synthetic hemodialysis membranes. The EVAL membrane showed better microcirculatory response compared to the hf-PS membrane.

Related Concept Videos